title: Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients.
authors.affiliation: Department of Clinical Pharmacy, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
authors.forename: V
authors.initials: V
authors.lastname: Furlan
authors.forename: L
authors.initials: L
authors.lastname: Perello
authors.forename: E
authors.initials: E
authors.lastname: Jacquemin
authors.forename: D
authors.initials: D
authors.lastname: Debray
authors.forename: A M
authors.initials: AM
authors.lastname: Taburet
mesh_terms: D000592:Amino Acid Metabolism, Inborn Errors / Q000601:surgery; D001656:Biliary Atresia / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D004347:Drug Interactions; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006501:Hepatic Encephalopathy / Q000601:surgery; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology; D008297:Male; D011422:Propionates / Q000097:blood; D012293:Rifampin / Q000627:therapeutic use*; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*
chemical_list: D011422:Propionates; D004917:Erythromycin; D012293:Rifampin; D016559:Tacrolimus